NYSEAMERICAN:MYO - Myomo Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$1.26 -0.08 (-5.97 %)
(As of 02/20/2019 04:00 PM ET)
Previous Close$1.34
Today's Range$1.26 - $1.37
52-Week Range$1.25 - $5.52
Volume79,946 shs
Average Volume81,554 shs
Market Capitalization$15.67 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Myomo, Inc., a commercial stage medical robotics company, designs, develops, and produces myoelectric braces or orthotics for people suffering with neuromuscular disorders in the United States. It offers MyoPro, a powered upper limb orthosis that supports the arm, as well as restores function to the weakened or paralyzed arms of patients suffering from CVA stroke, brachial plexus injury, traumatic brain injury, spinal cord injury, ALS, or other neuromuscular disease or injury. The company serves orthotics and prosthetics practices or clinics, as well as the veteran administration and other hospitals through orthotics and prosthetics providers, and distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Cambridge, Massachusetts.

Receive MYO News and Ratings via Email

Sign-up to receive the latest news and ratings for MYO and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NYSEAMERICAN
Industry Medical Devices
Sub-IndustryN/A
SectorMedical
Current SymbolNYSEAMERICAN:MYO
CUSIPN/A
Phone+1-617-9969058

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees22
Market Cap$15.67 million
OptionableNot Optionable

Myomo (NYSEAMERICAN:MYO) Frequently Asked Questions

What is Myomo's stock symbol?

Myomo trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "MYO."

How were Myomo's earnings last quarter?

Myomo Inc (NYSEAMERICAN:MYO) issued its quarterly earnings results on Tuesday, August, 7th. The company reported ($0.21) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.19) by $0.02. The company earned $0.63 million during the quarter, compared to the consensus estimate of $0.62 million. View Myomo's Earnings History.

When is Myomo's next earnings date?

Myomo is scheduled to release their next quarterly earnings announcement on Wednesday, March 6th 2019. View Earnings Estimates for Myomo.

What price target have analysts set for MYO?

2 analysts have issued 12 month target prices for Myomo's stock. Their predictions range from $7.00 to $12.00. On average, they anticipate Myomo's share price to reach $9.50 in the next twelve months. This suggests a possible upside of 654.0% from the stock's current price. View Analyst Price Targets for Myomo.

What is the consensus analysts' recommendation for Myomo?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Myomo in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Myomo.

Has Myomo been receiving favorable news coverage?

Media stories about MYO stock have trended neutral this week, according to InfoTrie. The research group ranks the sentiment of media coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Myomo earned a daily sentiment score of 0.3 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 5.0 out of 10, meaning that recent media coverage is somewhat likely to have an impact on the company's share price in the next few days.

Are investors shorting Myomo?

Myomo saw a drop in short interest in the month of January. As of January 31st, there was short interest totalling 545,305 shares, a drop of 10.3% from the January 15th total of 608,064 shares. Based on an average daily trading volume, of 47,869 shares, the days-to-cover ratio is currently 11.4 days. Approximately 5.3% of the shares of the company are short sold. View Myomo's Current Options Chain.

Who are some of Myomo's key competitors?

Who are Myomo's key executives?

Myomo's management team includes the folowing people:
  • Mr. Paul R. Gudonis, Chairman, Pres & CEO (Age 64)
  • Ms. Davie Mendelsohn RN, VP of Sales & Clinical Services (Age 65)
  • Mr. Jonathan Naft, VP & GM (Age 54)
  • Mr. Ralph A. Goldwasser, Chief Financial Officer (Age 71)
  • Mr. Clifford J. Conneighton, Chief Marketing Officer (Age 69)

Who are Myomo's major shareholders?

Myomo's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Bank of New York Mellon Corp (0.38%).

Which institutional investors are buying Myomo stock?

MYO stock was bought by a variety of institutional investors in the last quarter, including Bank of New York Mellon Corp.

How do I buy shares of Myomo?

Shares of MYO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Myomo's stock price today?

One share of MYO stock can currently be purchased for approximately $1.26.

How big of a company is Myomo?

Myomo has a market capitalization of $15.67 million. Myomo employs 22 workers across the globe.

What is Myomo's official website?

The official website for Myomo is http://myomo.com/.

How can I contact Myomo?

Myomo's mailing address is One Broadway, 14Th Floor, CAMBRIDGE, MA 02142, United States. The company can be reached via phone at +1-617-9969058.


MarketBeat Community Rating for Myomo (NYSEAMERICAN MYO)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  101 (Vote Outperform)
Underperform Votes:  96 (Vote Underperform)
Total Votes:  197
MarketBeat's community ratings are surveys of what our community members think about Myomo and other stocks. Vote "Outperform" if you believe MYO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MYO will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/20/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel